DK388484A - Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel - Google Patents

Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel Download PDF

Info

Publication number
DK388484A
DK388484A DK388484A DK388484A DK388484A DK 388484 A DK388484 A DK 388484A DK 388484 A DK388484 A DK 388484A DK 388484 A DK388484 A DK 388484A DK 388484 A DK388484 A DK 388484A
Authority
DK
Denmark
Prior art keywords
chromonalkaloid
medicine
isolated
dysoxylum binectariferum
binectariferum
Prior art date
Application number
DK388484A
Other languages
Danish (da)
English (en)
Other versions
DK388484D0 (da
Inventor
Sujata Vasudev Bhat
Virbala Shah
Alihussein Nomanbha Dohadwalla
Sadashiv Shantaram Mandrekar
Noel John De Souza
Gerhard Dickneite
Roland Kurrle
Hans-Ulrich Schorlemmer
Hans-Harald Sedlacek
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK388484D0 publication Critical patent/DK388484D0/da
Publication of DK388484A publication Critical patent/DK388484A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK388484A 1983-08-12 1984-08-10 Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel DK388484A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833329186 DE3329186A1 (de) 1983-08-12 1983-08-12 Chromonalkaloid, verfahren zu seiner isolierung aus dysoxylum binectariferum, und seine verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
DK388484D0 DK388484D0 (da) 1984-08-10
DK388484A true DK388484A (da) 1985-02-13

Family

ID=6206424

Family Applications (1)

Application Number Title Priority Date Filing Date
DK388484A DK388484A (da) 1983-08-12 1984-08-10 Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel

Country Status (6)

Country Link
US (1) US4603137A (fr)
EP (1) EP0137193A3 (fr)
JP (1) JPS6058977A (fr)
DE (1) DE3329186A1 (fr)
DK (1) DK388484A (fr)
ZA (1) ZA846211B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (fr) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
EP0508347A1 (fr) * 1991-04-10 1992-10-14 Hoechst Aktiengesellschaft 5,7-dihydroxy-2-méthyl-8-[4-(3-hydroxy-1-(1-propyl))pipéridinyl]4H-1-benzopyran-4-one, sa préparation et son utilisation
US5733920A (en) * 1995-10-31 1998-03-31 Mitotix, Inc. Inhibitors of cyclin dependent kinases
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
AU767241B2 (en) * 1998-09-14 2003-11-06 Qiang Xu Immunosuppressive agents
DE10113513A1 (de) * 2001-03-20 2002-10-02 Medinnova Ges Med Innovationen Kombinationspräparat zur Prophylaxe und/oder Therapie von Nervenzell- und/oder Gliazellschäden durch ein neues Behandlungsverfahren
CA2571710A1 (fr) 2004-06-24 2006-11-02 Nicholas Valiante Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
BRPI0402875A (pt) 2004-07-21 2006-03-07 Fundacao Oswaldo Cruz composições medicamentosas à base de extrato de carapa guianensis e/ou dos compostos quìmicos isolados desse extrato
JP2008255008A (ja) * 2005-07-19 2008-10-23 Tokyo Medical & Dental Univ 滑膜細胞増殖抑制剤
US9018006B2 (en) 2010-07-23 2015-04-28 The University Of Toledo Stable Tregs and related materials and methods
WO2018094275A1 (fr) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Promédicaments de l'alvocidib et leur utilisation en tant qu'inhibiteurs de protéines kinases
US11497756B2 (en) 2017-09-12 2022-11-15 Sumitomo Pharma Oncology, Inc. Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
KR20210099066A (ko) 2018-12-04 2021-08-11 스미토모 다이니폰 파마 온콜로지, 인크. 암의 치료를 위한 작용제로서 사용하기 위한 cdk9 억제제 및 그의 다형체
JP2022525149A (ja) 2019-03-20 2022-05-11 スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド ベネトクラクスが失敗した急性骨髄性白血病（ａｍｌ）の処置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB882537A (en) * 1958-09-12 1961-11-15 Recordati Lab Farmacologico S Chromones and processes for the preparation thereof
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives

Also Published As

Publication number Publication date
JPS6058977A (ja) 1985-04-05
EP0137193A2 (fr) 1985-04-17
DK388484D0 (da) 1984-08-10
EP0137193A3 (fr) 1987-02-04
ZA846211B (en) 1985-03-27
US4603137A (en) 1986-07-29
DE3329186A1 (de) 1985-02-21

Similar Documents

Publication Publication Date Title
DK158891C (da) Zeolitter, fremgangsmaade til fremstilling heraf samt anvendelse heraf
DK522383D0 (da) Aluminium-n-phosphonomethylglycin og dets anvendelse som herbicid
DK163984C (da) Dampmodificeret krystallinsk galloaluminosilicat, fremgangsmaade til dets fremstilling samt dets anvendelse
DK49283A (da) Pyrazoloxaziner, -thiaziner og -quinoliner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK388484A (da) Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel
IT8419789A0 (it) Chiusura per bottiglie.
FI864267A0 (fi) Modifierad process foer satsvis rening av sio2 i naerliggande fraktioner.
DK98182A (da) Fungicidt praeparat,fremgangsmaade til dets fremstilling samt anvendelse deraf
DK246984D0 (da) Dihydrobenzopyrrolobenzodiazepiner en fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
FI842818A (fi) Anvaendningsanordning foer aerosol.
BR8200926A (pt) Cabeco de fraturas
NO880186L (no) Tetrapeptidinhibitor samt fremgangsmaate for dets fremstilling og anvendelse derav.
DK342182A (da) Dispergeringsmiddel, fremgangsmaade til fremstilling heraf samt dets anvendelse
DK179784D0 (da) Krystallinsk zinksilicat, fremgangsmade til dets fremstilling samt dets anvendelse
DK382283A (da) Thiazol-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK406484A (da) 16-flour-16,17-didehydroprostanoider samt fremgangsmaade til og mellemprodukter ved fremstilling heraf
DK402685A (da) Alfa-glucosidaseinhibitor, dets fremstilling og anvendelse samt farmaceutiske praeparater
NO162962C (no) Diaminoalkoholer og anvendelse derav som midler for fjernelse av sure gasser.
DK177281A (da) Monohydratiseret isophtalsyrepicolylamid fremgangsmaade til dets fremstilling samt dets anvendelse
FI860597A (fi) Foerfarande foer framstaellning av en substituerad fenylurea.
DK247884D0 (da) Substituerede tetrahydrothiopyran-3,5-dion-4-carboxamider,fremgangsmaade til deres fremstilling og deres anvendelse samt mellemprodukter til fremstillingen
DK56985A (da) Substituerede benzopentathiepiner, fremgangsmaade til fremstilling deraf samt mellemprodukter til anvendelse herved
DK329882A (da) Oxothienobenzoxepiner,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK498386D0 (da) Copolymerisat, fremgangsmaade til dets fremstilling og dets anvendelse som enzymbaerer
DK353382A (da) N-(dichlorfluormethylthio)-3,6-endomethylen-delta4-tetrahydrophthalimid,fremgangsmaade til fremstilling heraf samt dets anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn